Susquehanna International Group’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.92M | Buy |
213,635
+156,587
| +274% | +$1.8M | 0.01% | 4707 |
|
|
2025
Q4 | $677K | Buy |
+57,048
| New | +$727K | ﹤0.01% | 8105 |
|
|
2025
Q2 | – | Sell |
-306
| Closed | -$6.42K | – | 13081 |
|
|
2025
Q1 | $6.42K | Sell |
306
-102
| -25% | -$2.73K | ﹤0.01% | 12245 |
|
|
2024
Q4 | $10.2K | Buy |
+408
| New | +$11.1K | ﹤0.01% | 11984 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 12452 |
|
|
2024
Q2 | – | Sell |
-5,546
| Closed | -$577K | – | 12552 |
|
|
2024
Q1 | $1.66M | Buy |
5,546
+4,431
| +397% | +$1.32M | ﹤0.01% | 5763 |
|
|
2023
Q4 | $263K | Buy |
+1,115
| New | +$173K | ﹤0.01% | 10100 |
|
|
2023
Q3 | – | Sell |
-421
| Closed | -$66.4K | – | 12435 |
|
|
2023
Q2 | $73.2K | Sell |
421
-500
| -54% | -$83.8K | ﹤0.01% | 11151 |
|
|
2023
Q1 | $116K | Sell |
921
-415
| -31% | -$93.4K | ﹤0.01% | 11165 |
|
|
2022
Q4 | $405K | Buy |
+1,336
| New | +$197K | ﹤0.01% | 8367 |
|
|
2022
Q3 | – | Sell |
-176
| Closed | -$11K | – | 13615 |
|
|
2022
Q2 | $11K | Sell |
176
-300
| -63% | -$22.2K | ﹤0.01% | 12493 |
|
|
2022
Q1 | $54K | Sell |
476
-2,176
| -82% | -$255K | ﹤0.01% | 12276 |
|
|
2021
Q4 | $382K | Buy |
2,652
+1,848
| +230% | +$335K | ﹤0.01% | 9896 |
|
|
2021
Q3 | $176K | Buy |
804
+213
| +36% | +$45.1K | ﹤0.01% | 11629 |
|
|
2021
Q2 | $137K | Buy |
591
+24
| +4% | +$6.11K | ﹤0.01% | 11902 |
|
|
2021
Q1 | $171K | Buy |
567
+113
| +25% | +$40.5K | ﹤0.01% | 11548 |
|
|
2020
Q4 | $171K | Sell |
454
-174
| -28% | -$61K | ﹤0.01% | 10159 |
|
|
2020
Q3 | $193K | Buy |
628
+320
| +104% | +$122K | ﹤0.01% | 9482 |
|
|
2020
Q2 | $116K | Buy |
308
+89
| +41% | +$25.2K | ﹤0.01% | 9421 |
|
|
2020
Q1 | $50K | Buy |
219
+88
| +67% | +$33.6K | ﹤0.01% | 9685 |
|
|
2019
Q4 | $69K | Sell |
131
-389
| -75% | -$211K | ﹤0.01% | 9259 |
|
|
2019
Q3 | $224K | Sell |
520
-498
| -49% | -$320K | ﹤0.01% | 8879 |
|
|
2019
Q2 | $1.21M | Buy |
1,018
+824
| +425% | +$985K | ﹤0.01% | 5223 |
|
|
2019
Q1 | $241K | Buy |
+194
| New | +$222K | ﹤0.01% | 7578 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 9579 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 9853 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 10106 |
|
|
2018
Q1 | – | Sell |
-1,780
| Closed | -$3.7M | – | 9810 |
|
|
2017
Q4 | $2.99M | Buy |
1,780
+614
| +53% | +$812K | 0.01% | 3252 |
|
|
2017
Q3 | $1.63M | Buy |
1,166
+234
| +25% | +$275K | 0.01% | 4300 |
|
|
2017
Q2 | $1.04M | Buy |
+932
| New | +$770K | ﹤0.01% | 5174 |
|
Other funds holding CBIO
BI
FFM
VA
FIS
VPC
OM
TCM
VCM